Our Mission...
is to improve the quality of health service delivery and reduce the burden of disease and disability in the United States and elsewhere by carrying out broadly based research and education activities involving the translation of innovative medical research into practice


James E. Haddow, M.D., Director

Glenn E. Palomaki, Ph.D., Associate Director

Linda A. Bradley, Ph.D., FACMG, Public Health Geneticist

Edward M. Kloza, M.S., Senior Research Coordinator (RNA Study)

George J. Knight, Ph.D., Associate Director, Laboratory Science

Louis M. Neveux, B.A., Senior Medical Statistician

Joanne M. Beaudoin, Office Manager


Linda A. Bradley, Ph.D., FACMG, Public Health Geneticist

Linda Bradley is a clinical geneticist who earned her bachelor’s degree in Biology at the University of Delaware, and her Ph.D. in Human Genetics from the University of North Carolina at Chapel Hill. She is certified by the American Board of Medical Genetics in clinical biochemical/molecular genetics, and is a founding Fellow of the American College of Medical Genetics. Dr. Bradley was a genetics laboratory director in both academic and commercial settings for more than 15 years, and has been active in genetics professional organizations, serving on the American College of Medical Genetics (ACMG)/American Society of Human Genetics Joint Test and Technology Transfer Committee (1996-2000), and the ACMG Quality Assurance Committee (2001-2004). She served as Director of Scientific Program Development at the Foundation for Blood Research from 1993-2000. In 2002, Dr. Bradley received an Association of Teachers of Preventive Medicine mid-career award to study public health at the Centers for Disease Control and Prevention (CDC), and joined Dr. Muin Khoury at the National Office of Public Health Genomics as a Geneticist one year later. As team lead for the CDC Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative (2004-2008), Dr. Bradley was instrumental in developing an independent process for the systematic evidence-based evaluation of genetic and genomic tests in translation from research to clinical and public health practice. During her six years at CDC, Dr. Bradley received a CDC Director’s Innovation Award, a National Center for Chronic Disease Prevention and Health Promotion Certificate of Appreciation for Excellence in Innovation, and a US Food and Drug Administration Commissioner’s Special Citation for an inter-agency collaborative alert on At-Home Genetic Tests. She is now a Public Health Geneticist at the Division of Medical Screening and Special Testing at Women & Infants Hospital of Rhode Island. Dr. Bradley has numerous publications in scientific journals, does technical consulting, and serves on national and international committees and advisory boards.